411 материалов по теме, собраны автоматически из проверенных источников
The Journal of Clinical Oncology has published secondary results from the ECOG-ACRIN Cancer Research Group's CompassHER2-pCR clinical trial (EA1181, NCT04266249). The findings help identify which early-stage HER2-positive (HER2+) breast cancers may be most likely to respond to less intensive chemotherapy than the…
Exploring Early Breast Cancer: Advancing Research Across the Treatment Journey Daiichi Sankyo US
Approximately a third of patients with breast cancer reported increased fatigue 2 years after receiving chemotherapy, but addressing any depression and/or stress may significantly reduce this lethargy. This cohort study including nearly 400 women also showed common evaluations clinicians perform when diagnosing…
New Phase III Trial Uses MRD Testing to Personalize Treatment for Early-Stage Breast Cancer - Alliance for Clinical Trials in Oncology Oncodaily
Unlocking New Possibilities in Metastatic Breast Cancer Treatment Targeted Oncology
Dr Premji on Community Trials and the Evolving Breast Cancer Landscape Targeted Oncology
IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site PR Newswire
IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site PR Newswire
AFT, Natera launch Phase III to test MRD-guided deferral of CDK4/6 therapy in early breast cancer AllSci
A model that uses readily available clinical data can help predict risk for near-term death among patients with metastatic breast cancer, according to study results. The tool predicted 90-day mortality with accuracy ranging from 72% to 83% during internal testing. Researchers observed similar performance in external…
Avoid dairy, fruit and red meat; take vitamin D supplements—these are some of the nutrition claims circulating online for breast cancer patients, but how many of them are actually based on fact?
Major HER2+ breast cancer trial identifies factors associated with pathologic complete response to less intensive chemotherapy EurekAlert! Science News Releases
Real-World Data Confirm Immunotherapy Boost for Aggressive Early Breast Cancer Bioengineer.org
Run for the Cure Unites 65,000 to Advance Breast Cancer Research - Canadian Cancer Society oncodaily.com
Landmark Trial Pinpoints Which HER2-Positive Breast Cancers Respond to Shorter, Gentler Chemotherapy Bioengineer.org